STAT1 and non-small cell lung carcinoma: Likewise, low‐dose suberoylanilide hydroxamic acid (SAHA) enhances MHC‐I expression in NSCLC cells by increasing H3K9ac and H3K27ac at the promoters of STAT1, Smad2, and Smad3 through histone deacetylase (HDAC) inhibition.